Patent details
EP2870250 Title: CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF
Basic Information
- Publication number:
- EP2870250
- PCT Application Number:
- US2013049460
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP138132253
- PCT Publication Number:
- WO2014008480
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF
- French Title of Invention:
- LIGNÉE CELLULAIRE EXPRIMANT DES POLYPEPTIDES DE FACTEUR VIII À UNE SEULE CHAÎNE ET SES UTILISATIONS
- German Title of Invention:
- EINKETTIGE FAKTOR-VIII-POLYPEPTIDE EXPRIMIERENDE ZELLLINIE UND VERWENDUNGEN DAVON
- SPC Number:
Dates
- Filing date:
- 05/07/2013
- Grant date:
- 18/04/2018
- EP Publication Date:
- 13/05/2015
- PCT Publication Date:
- 09/01/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/04/2018
- EP B1 Publication Date:
- 18/04/2018
- EP B2 Publication Date:
- 29/06/2022
- EP B3 Publication Date:
- Lapsed date:
- 05/07/2023
- Expiration date:
- 05/07/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/06/2022
- Name:
- Bioverativ Therapeutics Inc.
- Address:
- 225 Second Avenue, Waltham, MA 02451, United States (US)
Agent
- Name:
- STOLMÁR & PARTNER
- From:
- 09/07/2018
- Address:
- BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
- To:
Inventor
1
- Name:
- LOW, Susan
- Address:
- United States (US)
2
- Name:
- BITONTI, Alan J.
- Address:
- United States (US)
3
- Name:
- DUMONT, Jennifer A.
- Address:
- United States (US)
Priority
- Priority Number:
- 201261668889 P
- Priority Date:
- 06/07/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 15/85;
Publication
European Patent Bulletin
1
- Issue number:
- 201816
- Publication date:
- 18/04/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201909
- Publication date:
- 27/02/2019
- Description:
- Opposition procedure started
3
- Issue number:
- 202226
- Publication date:
- 29/06/2022
- Description:
- Patent maintained (B2 publication)
4
- Issue number:
- 201821
- Publication date:
- 23/05/2018
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/06/2022
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 131 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 12/07/2018 | Outgoing Correspondence | 1 |